At the Burke Neurological Institute (BNI), our researchers are diving deeper to discover new and innovative therapies and support for individuals living with Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth (CMT), Spinal Muscular Atrophy (SMA), and other related neuromuscular diseases.
Burke Neurological Institute (BNI) is deeply saddened by the passing of an incredibly kind and thoughtful colleague, Dr. M. Flint Beal. As one of the greatest clinician-scientists of his generation, Dr.
In a landmark research study on eighty-two children with spastic cerebral palsy (CP) on one side of the body, researchers at Burke Neurological Institute, Teacher’s College-Columbia University, and Weill Cornell Medicine learned that two intensive training therapies improved hand and arm function, allowing children to learn new, long-term life skills regardless of how the injured brain had re-wired itself.
Today, scientists still do not know the cause of Alzheimer’s disease (AD), yet decades of research advancements give hope to the possibility of slowing down early-onset of AD. Benfotiamine, a therapeutic drug that raises blood vitamin B1, levels very high, was recently tested as a pilot clinical study conducted by the Gibson Lab at the Burke Neurological Institute.